-
Palo Alto Is A 'Next Generation Leader' In Argus' View
Thursday, September 1, 2016 - 8:50am | 347Read More...Palo Alto Networks Inc (NYSE: PANW) has superior technology, and is a “next-generation leader in the enterprise security space,” Argus’s Joseph Bonner said in a report. He maintained a Buy rating on the company, with a price target of $205, following strong July quarter results...
-
Argus Says Advance Auto Parts' New CEO Is 'The Right Executive For The Job'
Wednesday, August 31, 2016 - 11:57am | 356Read More...Argus is positive on Advance Auto Parts, Inc. (NYSE: AAP)'s hiring of Tom Greco as CEO, as it thinks he "is the right executive for the job." The brokerage's analysts commented, "[H]e will deliver operating improvements that will be a catalyst for the shares." Argus maintains its Buy rating and $...
-
Brocade's Post-Earnings Selloff May Have Provided An Entry Point
Wednesday, August 31, 2016 - 10:35am | 388Read More...Brocade Communications Systems, Inc. (NASDAQ: BRCD) shares took a beating following the above-consensus results, which revealed weakness in the core business. Argus’ Jim Kelleher reiterated a Buy rating on the company with a price target of $13. Entry Point Kelleher believes the selloff...
-
Argus Downgrades First Solar On Price Competition Concerns
Wednesday, August 31, 2016 - 10:19am | 440Read More...Argus’ Stephen Biggar expressed concern regarding First Solar, Inc. (NASDAQ: FSLR)'s declining project backlog, as well as the impact of strong price competition. Biggar downgraded the rating on the company from Buy to Hold. EPS Concerns The analyst expects the company’s EPS to be hurt...
-
Under Armour Downgraded: New Investments May Put A Damper On Earnings Growth
Wednesday, August 31, 2016 - 8:49am | 340Read More...Although Under Armour Inc (NYSE: UA) would likely generate robust revenue going forward, substantial investment to expand the business could weigh on earnings growth, Argus’s John Staszak said in a report. He downgraded the rating on the company from Buy to Hold. Under Armour’s...
-
Argus Raises Dick's Sporting Goods Price Target, Expects Market Share Gains
Tuesday, August 30, 2016 - 11:22am | 338Read More...Argus’ Christopher Graja expects Dicks Sporting Goods Inc (NYSE: DKS) to gain market share due to the bankruptcy of The Sports Authority. Graja reiterated a Buy rating on the company, while raising the price target from $52 to $66. Growth Expectations The analyst also expects the company to...
-
Vornado Realty Appears Likely To Spin Off D.C. Properties
Tuesday, August 30, 2016 - 10:15am | 286Read More...Vornado Realty Trust (NYSE: VNO), which is undergoing a business transition process to strengthening its core operations, has spun-off its shopping center unit and could do the same with its Washington D.C. properties, Argus’s Jacob Kilstein said in a report. He maintained a Hold rating on...
-
Rio Tinto Looks Poised To Capitalize On An Industry Turnaround
Tuesday, August 30, 2016 - 9:51am | 303Read More...Rio Tinto plc (ADR) (NYSE: RIO) has responded to weak commodity prices with cost control, asset sales and lower capex, and now appears poised to benefit from an industry turnabout, Argus’s John Eade said in a report. He maintained a Buy rating on the company, with a price target of $36....
-
BHP Billiton Raised To Buy At Argus On Positive Outlook For Materials
Tuesday, August 30, 2016 - 9:23am | 310Read More...Although sales and earnings at BHP Billiton Limited (ADR) (NYSE: BHP) have been hit by declining commodity prices, many product prices seem to be “nearing a cycle bottom,” Argus’s John Eade said in a report. He upgraded the rating on the company to Buy, while establishing a...
-
In Wake Of Medivation Deal, Argus Thinks Pfizer's Existing Business Is Underrated
Monday, August 29, 2016 - 11:21am | 376Read More...On August 22, Pfizer Inc. (NYSE: PFE) announced it had entered into an agreement to acquire Medivation Inc (NASDAQ: MDVN) for almost $14 billion or $81.50 per shares. Argus’ Jacob Kilstein maintains a Buy rating on Pfizer with a price target of $39. The Acquisition Kilstein mentioned the...
-
Argus Upgrades AstraZeneca To Buy, Says Discount Is Too Steep Against Pipeline Potential
Monday, August 29, 2016 - 10:39am | 274Read More...AstraZeneca plc (ADR) (NYSE: AZN) shares are currently trading at a discount to S&P 500 pharma companies. Argus’ John Eade believes the discount is too steep given the company’s pipeline potential. Eade upgraded the rating on the company to Buy with a price target of $38. Coping...
-
Argus Raises Price Target On HP, Sees Improving Margins And A Balanced Business Mix
Monday, August 29, 2016 - 9:13am | 304Read More...HP Inc (NYSE: HPQ) reported robust Q3 results, with solid printing profits and the PC business gaining share. The company is “managing through secular transitions and cyclical challenges, while boosting margins at an impressive pace,” Argus’s Jim Kelleher said in a report. He...
-
Argus On Ventas: Looking For A Pullback To $62
Friday, August 26, 2016 - 3:43pm | 355Read More...Argus has maintained its Hold rating on Ventas, Inc. (NYSE: VTR) as it expects growth to be constrained in the near term by asset sales and dilutive equity issuance, despite having opportunities in the $1 trillion senior housing and healthcare real estate market. However, the brokerage said shares...
-
Argus Calls Williams-Sonoma The Best Positioned In Its Coverage Universe To Capitalize On Online Shoppers
Friday, August 26, 2016 - 10:13am | 299Read More...Williams-Sonoma, Inc. (NYSE: WSM) reported flat Q2 EPS. Although the company is improving its supply chain and its inventories are “in good shape,” consumer trends and mall traffic remain weak, Argus’s Chris Graja said in a report. He maintained a Buy rating on Williams-Sonoma,...
-
St. Jude's Abbott Merger On Track For Q4
Friday, August 26, 2016 - 9:02am | 273Read More...St. Jude Medical, Inc. (NYSE: STJ) expects to complete its merger with Abbott Laboratories (NYSE: ABT) by yearend 2016. Argus’s David Toung maintained a Hold rating on St. Jude, citing the pending acquisition. St. Jude reported its Q2 adjusted EPS at $1.06, up from $1.03 a year earlier....













